Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 1829 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 3841 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 5520 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 6022 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | BS4 | IFN-G | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | BS4 | Untreated | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | HAHA | IFN-G | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | HAHA | TNF-alpha | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | HAHA | Untreated | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | PAK | IL-17A | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | PAK | TNF-alpha | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | PAK | Untreated | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1361 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1869 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | BS4 | IL-17A | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | BS4 | TNF-alpha | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | BS4 | Untreated | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | HAHA | IFN-G | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | HAHA | TNF-alpha | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | HAHA | Untreated | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | PAK | IFN-G | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | PAK | TNF-alpha | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | PAK | Untreated |